The World Market for Molecular Diagnostics, 12th Edition

Description:

Exploring the Dynamic Landscape of Post-Pandemic Molecular Diagnostics

Kalorama Information’s comprehensive market research report, The World Market for Molecular Diagnostics, 12th Edition, delves into the evolving molecular diagnostics sector, uncovering the opportunities and challenges that have emerged in the post-pandemic era.

 

Overview

In recent years, molecular diagnostics has become the fastest-growing segment within the global in vitro diagnostics (IVD) market, significantly influenced by the COVID-19 pandemic. This report examines the current state of the multi-billion-dollar molecular diagnostic market, highlighting key areas of opportunity in infectious diseases, cancer, and transplant diagnostics. North America and Europe continue to lead the global demand, with the market poised for further growth.

 

Molecular diagnostics is now a critical tool in clinical medicine, impacting various aspects of healthcare. It plays a vital role in treatment decisions by quickly identifying antimicrobial-resistant (AMR) infections. It also supports companion diagnostics, helping assess the suitability of different cancer treatments. Moreover, molecular diagnostics is essential for understanding patient metabolism of drugs for conditions like HIV, psychiatric disorders, or blood thinners, and its applications extend to cancer prognosis, organ matching, blood safety, and the diagnosis of latent and neonatal conditions.

 

Key Insights and Market Segments

This report provides an in-depth analysis of global and regional markets for molecular diagnostics, covering:

• Global Markets for Molecular Diagnostics by Application Segments (2023-2028): Including Infectious Diseases, Blood Screening, Histology, Cancer Assays, Transplant, and Inherited Diseases.
• North American Markets for Molecular Diagnostics (2023-2028): Detailed analysis by application segments.
• European Markets for Molecular Diagnostics (2023-2028): Comprehensive insights by application segments.
• Asia Pacific Markets for Molecular Diagnostics (2023-2028): Regional analysis by application segments.

 

For further details and to purchase directly, please contact us.

Sample Report: A sample is available as a PDF upon request.

 

 

 

 

Table: Growth Applications, by Revenue Growth, 2023 (%)

Application	Revenue Growth (%)
Cancer Assays	XX%
TB	XX%
Histology (ISH, FISH)	XX%
NIPT	XX%
Respiratory	XX%
Molecular HPV	XX%
Hepatitis	XX%
Transplantation	XX%
HAIs/ sepsis	XX%
Inherited/ genetic	XX%
STIs	XX%
HIV	XX%
Circulating tumor cells	XX%

Source: Kalorama Information